INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING CANCER BY ADMINISTERING A COMBINATION THERAPY INCLUDING A NEOADJUVANT PD-1 INHIBITOR"

GENEVA, June 12 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2024/057962) for "METHODS OF TREATING CANCER BY ADMINISTERING A COMBINATION THERAPY INCLUDING A NEOADJUVANT PD-1 INHIBITOR" on Nov 29, 2024. With publication no. WO/2025/117889, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MILLER, Elizabeth (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York 10591), LOWY, Israel (c/o Regeneron Pharmaceuticals, Inc.777...